ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Crigler-Najjar Syndrome Drug Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-38Y9739
Home | Market Reports | Health| Pharmacy
Global Crigler Najjar Syndrome Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Crigler-Najjar Syndrome Drug Market Research Report 2025

Code: QYRE-Auto-38Y9739
Report
January 2025
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Audentes Therapeutics Inc
Genethon SA
International Stem Cell Corp
Promethera Biosciences SA

Crigler-Najjar Syndrome Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Crigler-Najjar Syndrome Drug Market

Crigler-Najjar Syndrome Drug Market

The global market for Crigler-Najjar Syndrome Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Crigler-Najjar Syndrome Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crigler-Najjar Syndrome Drug.
The Crigler-Najjar Syndrome Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Crigler-Najjar Syndrome Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crigler-Najjar Syndrome Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Crigler-Najjar Syndrome Drug Market Report

Report Metric Details
Report Name Crigler-Najjar Syndrome Drug Market
CAGR 5%
Segment by Type
  • ALXN-1540
  • AT-342
  • HepaStem
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Audentes Therapeutics Inc, Genethon SA, International Stem Cell Corp, Promethera Biosciences SA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Crigler-Najjar Syndrome Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Crigler-Najjar Syndrome Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Crigler-Najjar Syndrome Drug Market report?

Ans: The main players in the Crigler-Najjar Syndrome Drug Market are Audentes Therapeutics Inc, Genethon SA, International Stem Cell Corp, Promethera Biosciences SA

What are the Application segmentation covered in the Crigler-Najjar Syndrome Drug Market report?

Ans: The Applications covered in the Crigler-Najjar Syndrome Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Crigler-Najjar Syndrome Drug Market report?

Ans: The Types covered in the Crigler-Najjar Syndrome Drug Market report are ALXN-1540, AT-342, HepaStem, Others

Recommended Reports

Rare Disease Drugs

Neurology Medicines

Autoimmune & Inflammation

1 Crigler-Najjar Syndrome Drug Market Overview
1.1 Product Definition
1.2 Crigler-Najjar Syndrome Drug by Type
1.2.1 Global Crigler-Najjar Syndrome Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 ALXN-1540
1.2.3 AT-342
1.2.4 HepaStem
1.2.5 Others
1.3 Crigler-Najjar Syndrome Drug by Application
1.3.1 Global Crigler-Najjar Syndrome Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Crigler-Najjar Syndrome Drug Market Size Estimates and Forecasts
1.4.1 Global Crigler-Najjar Syndrome Drug Revenue 2020-2031
1.4.2 Global Crigler-Najjar Syndrome Drug Sales 2020-2031
1.4.3 Global Crigler-Najjar Syndrome Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Crigler-Najjar Syndrome Drug Market Competition by Manufacturers
2.1 Global Crigler-Najjar Syndrome Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Crigler-Najjar Syndrome Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Crigler-Najjar Syndrome Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Crigler-Najjar Syndrome Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Crigler-Najjar Syndrome Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Crigler-Najjar Syndrome Drug, Product Type & Application
2.7 Global Key Manufacturers of Crigler-Najjar Syndrome Drug, Date of Enter into This Industry
2.8 Global Crigler-Najjar Syndrome Drug Market Competitive Situation and Trends
2.8.1 Global Crigler-Najjar Syndrome Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Crigler-Najjar Syndrome Drug Players Market Share by Revenue
2.8.3 Global Crigler-Najjar Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Crigler-Najjar Syndrome Drug Market Scenario by Region
3.1 Global Crigler-Najjar Syndrome Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Crigler-Najjar Syndrome Drug Sales by Region: 2020-2031
3.2.1 Global Crigler-Najjar Syndrome Drug Sales by Region: 2020-2025
3.2.2 Global Crigler-Najjar Syndrome Drug Sales by Region: 2026-2031
3.3 Global Crigler-Najjar Syndrome Drug Revenue by Region: 2020-2031
3.3.1 Global Crigler-Najjar Syndrome Drug Revenue by Region: 2020-2025
3.3.2 Global Crigler-Najjar Syndrome Drug Revenue by Region: 2026-2031
3.4 North America Crigler-Najjar Syndrome Drug Market Facts & Figures by Country
3.4.1 North America Crigler-Najjar Syndrome Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Crigler-Najjar Syndrome Drug Sales by Country (2020-2031)
3.4.3 North America Crigler-Najjar Syndrome Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Crigler-Najjar Syndrome Drug Market Facts & Figures by Country
3.5.1 Europe Crigler-Najjar Syndrome Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Crigler-Najjar Syndrome Drug Sales by Country (2020-2031)
3.5.3 Europe Crigler-Najjar Syndrome Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Crigler-Najjar Syndrome Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Crigler-Najjar Syndrome Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Crigler-Najjar Syndrome Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Crigler-Najjar Syndrome Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Crigler-Najjar Syndrome Drug Market Facts & Figures by Country
3.7.1 Latin America Crigler-Najjar Syndrome Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Crigler-Najjar Syndrome Drug Sales by Country (2020-2031)
3.7.3 Latin America Crigler-Najjar Syndrome Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Crigler-Najjar Syndrome Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Crigler-Najjar Syndrome Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Crigler-Najjar Syndrome Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Crigler-Najjar Syndrome Drug Sales by Type (2020-2031)
4.1.1 Global Crigler-Najjar Syndrome Drug Sales by Type (2020-2025)
4.1.2 Global Crigler-Najjar Syndrome Drug Sales by Type (2026-2031)
4.1.3 Global Crigler-Najjar Syndrome Drug Sales Market Share by Type (2020-2031)
4.2 Global Crigler-Najjar Syndrome Drug Revenue by Type (2020-2031)
4.2.1 Global Crigler-Najjar Syndrome Drug Revenue by Type (2020-2025)
4.2.2 Global Crigler-Najjar Syndrome Drug Revenue by Type (2026-2031)
4.2.3 Global Crigler-Najjar Syndrome Drug Revenue Market Share by Type (2020-2031)
4.3 Global Crigler-Najjar Syndrome Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Crigler-Najjar Syndrome Drug Sales by Application (2020-2031)
5.1.1 Global Crigler-Najjar Syndrome Drug Sales by Application (2020-2025)
5.1.2 Global Crigler-Najjar Syndrome Drug Sales by Application (2026-2031)
5.1.3 Global Crigler-Najjar Syndrome Drug Sales Market Share by Application (2020-2031)
5.2 Global Crigler-Najjar Syndrome Drug Revenue by Application (2020-2031)
5.2.1 Global Crigler-Najjar Syndrome Drug Revenue by Application (2020-2025)
5.2.2 Global Crigler-Najjar Syndrome Drug Revenue by Application (2026-2031)
5.2.3 Global Crigler-Najjar Syndrome Drug Revenue Market Share by Application (2020-2031)
5.3 Global Crigler-Najjar Syndrome Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Audentes Therapeutics Inc
6.1.1 Audentes Therapeutics Inc Company Information
6.1.2 Audentes Therapeutics Inc Description and Business Overview
6.1.3 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Product Portfolio
6.1.5 Audentes Therapeutics Inc Recent Developments/Updates
6.2 Genethon SA
6.2.1 Genethon SA Company Information
6.2.2 Genethon SA Description and Business Overview
6.2.3 Genethon SA Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Genethon SA Crigler-Najjar Syndrome Drug Product Portfolio
6.2.5 Genethon SA Recent Developments/Updates
6.3 International Stem Cell Corp
6.3.1 International Stem Cell Corp Company Information
6.3.2 International Stem Cell Corp Description and Business Overview
6.3.3 International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 International Stem Cell Corp Crigler-Najjar Syndrome Drug Product Portfolio
6.3.5 International Stem Cell Corp Recent Developments/Updates
6.4 Promethera Biosciences SA
6.4.1 Promethera Biosciences SA Company Information
6.4.2 Promethera Biosciences SA Description and Business Overview
6.4.3 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Product Portfolio
6.4.5 Promethera Biosciences SA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Crigler-Najjar Syndrome Drug Industry Chain Analysis
7.2 Crigler-Najjar Syndrome Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Crigler-Najjar Syndrome Drug Production Mode & Process Analysis
7.4 Crigler-Najjar Syndrome Drug Sales and Marketing
7.4.1 Crigler-Najjar Syndrome Drug Sales Channels
7.4.2 Crigler-Najjar Syndrome Drug Distributors
7.5 Crigler-Najjar Syndrome Drug Customer Analysis
8 Crigler-Najjar Syndrome Drug Market Dynamics
8.1 Crigler-Najjar Syndrome Drug Industry Trends
8.2 Crigler-Najjar Syndrome Drug Market Drivers
8.3 Crigler-Najjar Syndrome Drug Market Challenges
8.4 Crigler-Najjar Syndrome Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Audentes Therapeutics Inc
Genethon SA
International Stem Cell Corp
Promethera Biosciences SA
List of Tables
 Table 1. Global Crigler-Najjar Syndrome Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Crigler-Najjar Syndrome Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Crigler-Najjar Syndrome Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Crigler-Najjar Syndrome Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Crigler-Najjar Syndrome Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Crigler-Najjar Syndrome Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Crigler-Najjar Syndrome Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Crigler-Najjar Syndrome Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Crigler-Najjar Syndrome Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Crigler-Najjar Syndrome Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Crigler-Najjar Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crigler-Najjar Syndrome Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Crigler-Najjar Syndrome Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Crigler-Najjar Syndrome Drug Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Crigler-Najjar Syndrome Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Crigler-Najjar Syndrome Drug Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Crigler-Najjar Syndrome Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Crigler-Najjar Syndrome Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Crigler-Najjar Syndrome Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Crigler-Najjar Syndrome Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Crigler-Najjar Syndrome Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Crigler-Najjar Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Crigler-Najjar Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Crigler-Najjar Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Crigler-Najjar Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Crigler-Najjar Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Crigler-Najjar Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Crigler-Najjar Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Crigler-Najjar Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Crigler-Najjar Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Crigler-Najjar Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Crigler-Najjar Syndrome Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Crigler-Najjar Syndrome Drug Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Crigler-Najjar Syndrome Drug Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Crigler-Najjar Syndrome Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Crigler-Najjar Syndrome Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Crigler-Najjar Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Crigler-Najjar Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Crigler-Najjar Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Crigler-Najjar Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Crigler-Najjar Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Crigler-Najjar Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Crigler-Najjar Syndrome Drug Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Crigler-Najjar Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Crigler-Najjar Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Crigler-Najjar Syndrome Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Crigler-Najjar Syndrome Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Crigler-Najjar Syndrome Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Crigler-Najjar Syndrome Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Crigler-Najjar Syndrome Drug Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Crigler-Najjar Syndrome Drug Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Crigler-Najjar Syndrome Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Crigler-Najjar Syndrome Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Crigler-Najjar Syndrome Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Crigler-Najjar Syndrome Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Crigler-Najjar Syndrome Drug Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Crigler-Najjar Syndrome Drug Price (USD/Pcs) by Application (2026-2031)
 Table 70. Audentes Therapeutics Inc Company Information
 Table 71. Audentes Therapeutics Inc Description and Business Overview
 Table 72. Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Product
 Table 74. Audentes Therapeutics Inc Recent Developments/Updates
 Table 75. Genethon SA Company Information
 Table 76. Genethon SA Description and Business Overview
 Table 77. Genethon SA Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Genethon SA Crigler-Najjar Syndrome Drug Product
 Table 79. Genethon SA Recent Developments/Updates
 Table 80. International Stem Cell Corp Company Information
 Table 81. International Stem Cell Corp Description and Business Overview
 Table 82. International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. International Stem Cell Corp Crigler-Najjar Syndrome Drug Product
 Table 84. International Stem Cell Corp Recent Developments/Updates
 Table 85. Promethera Biosciences SA Company Information
 Table 86. Promethera Biosciences SA Description and Business Overview
 Table 87. Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Promethera Biosciences SA Crigler-Najjar Syndrome Drug Product
 Table 89. Promethera Biosciences SA Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Crigler-Najjar Syndrome Drug Distributors List
 Table 93. Crigler-Najjar Syndrome Drug Customers List
 Table 94. Crigler-Najjar Syndrome Drug Market Trends
 Table 95. Crigler-Najjar Syndrome Drug Market Drivers
 Table 96. Crigler-Najjar Syndrome Drug Market Challenges
 Table 97. Crigler-Najjar Syndrome Drug Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Crigler-Najjar Syndrome Drug
 Figure 2. Global Crigler-Najjar Syndrome Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Crigler-Najjar Syndrome Drug Market Share by Type: 2024 & 2031
 Figure 4. ALXN-1540 Product Picture
 Figure 5. AT-342 Product Picture
 Figure 6. HepaStem Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Crigler-Najjar Syndrome Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Crigler-Najjar Syndrome Drug Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Others
 Figure 13. Global Crigler-Najjar Syndrome Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Crigler-Najjar Syndrome Drug Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Crigler-Najjar Syndrome Drug Sales (2020-2031) & (K Pcs)
 Figure 16. Global Crigler-Najjar Syndrome Drug Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Crigler-Najjar Syndrome Drug Report Years Considered
 Figure 18. Crigler-Najjar Syndrome Drug Sales Share by Manufacturers in 2024
 Figure 19. Global Crigler-Najjar Syndrome Drug Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Crigler-Najjar Syndrome Drug Players: Market Share by Revenue in Crigler-Najjar Syndrome Drug in 2024
 Figure 21. Crigler-Najjar Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Crigler-Najjar Syndrome Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Crigler-Najjar Syndrome Drug Sales Market Share by Country (2020-2031)
 Figure 24. North America Crigler-Najjar Syndrome Drug Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Crigler-Najjar Syndrome Drug Sales Market Share by Country (2020-2031)
 Figure 28. Europe Crigler-Najjar Syndrome Drug Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Crigler-Najjar Syndrome Drug Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Crigler-Najjar Syndrome Drug Revenue Market Share by Region (2020-2031)
 Figure 36. China Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Crigler-Najjar Syndrome Drug Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Crigler-Najjar Syndrome Drug Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Crigler-Najjar Syndrome Drug Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Crigler-Najjar Syndrome Drug Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Crigler-Najjar Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Crigler-Najjar Syndrome Drug by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Crigler-Najjar Syndrome Drug by Type (2020-2031)
 Figure 58. Global Crigler-Najjar Syndrome Drug Price (USD/Pcs) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Crigler-Najjar Syndrome Drug by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Crigler-Najjar Syndrome Drug by Application (2020-2031)
 Figure 61. Global Crigler-Najjar Syndrome Drug Price (USD/Pcs) by Application (2020-2031)
 Figure 62. Crigler-Najjar Syndrome Drug Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Schnitzler Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CGT Drugs Market Research Report 2025
Global Sicca Syndrome Drug Market Research Report 2024
Global Osteogenesis Imperfecta Treatment Market Research Report 2025
Global Nesiritide Drug Market Research Report 2024
Global Specific Learning Disability Treatment Market Research Report 2025
Barth Syndrome Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastro Esophageal Reflux Disease GERD Drug Market Research Report 2025
Global Crohn s Disease Drug Market Research Report 2024
Bartonellosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non invasive Prenatal Genetic Testing Market Research Report 2025
Global Amyloidosis Therapeutics Market Research Report 2024
Global Genetic Disease Diagnosis Market Research Report 2024
Chronic Granulomatous Disease CGD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Global Rare Disease Drug Market Research Report 2024
Global Poultry Disease Diagnostic Kit Market Research Report 2025
Hyperbilirubinemia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Baby Teething Drugs Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions